A series of 11 complexes of the type trans-(NHC) 2 Pt(CC-Ar) 2 (where NHC = N-heterocyclic carbene) have been synthesized and their photophysics characterized. The complexes display moderately efficient deep blue to green phosphorescence from a triplet excited state that is localized mainly in the aryl acetylide ligand (CC-Ar). The emission energy varies with the substituent on CC-Ar, with the highest energy emission for Ar = 4-pyridyl. The emission quantum efficiency and lifetime for the series decreases with increasing emission energy (E em ), and the effect is identified as arising from an increase in the nonradiative decay rate (k nr ) with E em . Temperature-dependent emission lifetime studies for three complexes give activation energies for the nonradiative decay process ∼1000 cm −1 , and the thermally activated decay process is attributed to crossing to a nonemissive metal-centered (d−d) excited state. At a low temperature, two different emission progressions are observed. Density functional theory calculations suggest that the triplet energy varies with the torsion of the aryl acetylide rings relative to the plane defined by the PtC 4 unit (where C = the carbon atoms bonded to Pt). The multiple emission is ascribed to emission from complexes differing with respect to the aryl acetylide ring torsion. Ultrafast transient absorption spectroscopy reveals a fast relaxation (∼5 ps) that may also be due to aryl acetylide ring torsional relaxation in the triplet excited state.
Cyclometalated gold(iii) aryls are prepared through palladium catalysis. Mono- and diarylation are demonstrated. A wide range of functional groups is tolerated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.